LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects

Detalles Bibliográficos
Autores principales: Borman, Pinar, Demir, Gülseren, Kaygısız, Ferda, Okumuş, Muyesser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157341/
https://www.ncbi.nlm.nih.gov/pubmed/25232363
http://dx.doi.org/10.2174/1874312901408010018
_version_ 1782333861966905344
author Borman, Pinar
Demir, Gülseren
Kaygısız, Ferda
Okumuş, Muyesser
author_facet Borman, Pinar
Demir, Gülseren
Kaygısız, Ferda
Okumuş, Muyesser
author_sort Borman, Pinar
collection PubMed
description
format Online
Article
Text
id pubmed-4157341
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-41573412014-09-17 LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects Borman, Pinar Demir, Gülseren Kaygısız, Ferda Okumuş, Muyesser Open Rheumatol J Article Bentham Open 2014-09-3 /pmc/articles/PMC4157341/ /pubmed/25232363 http://dx.doi.org/10.2174/1874312901408010018 Text en © Borman et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Borman, Pinar
Demir, Gülseren
Kaygısız, Ferda
Okumuş, Muyesser
LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
title LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
title_full LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
title_fullStr LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
title_full_unstemmed LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
title_short LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
title_sort letter to the editor subcutaneous (sc) methotrexate (mtx) is better and well-tolerable than oral mtx in rheumatoid arthritis patients, switched from oral to sc administration due to gastrointestinal side effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157341/
https://www.ncbi.nlm.nih.gov/pubmed/25232363
http://dx.doi.org/10.2174/1874312901408010018
work_keys_str_mv AT bormanpinar lettertotheeditorsubcutaneousscmethotrexatemtxisbetterandwelltolerablethanoralmtxinrheumatoidarthritispatientsswitchedfromoraltoscadministrationduetogastrointestinalsideeffects
AT demirgulseren lettertotheeditorsubcutaneousscmethotrexatemtxisbetterandwelltolerablethanoralmtxinrheumatoidarthritispatientsswitchedfromoraltoscadministrationduetogastrointestinalsideeffects
AT kaygısızferda lettertotheeditorsubcutaneousscmethotrexatemtxisbetterandwelltolerablethanoralmtxinrheumatoidarthritispatientsswitchedfromoraltoscadministrationduetogastrointestinalsideeffects
AT okumusmuyesser lettertotheeditorsubcutaneousscmethotrexatemtxisbetterandwelltolerablethanoralmtxinrheumatoidarthritispatientsswitchedfromoraltoscadministrationduetogastrointestinalsideeffects

Ejemplares similares